Sanara MedTech (SMTI) has issued an update.
Zachary B. Fleming has stepped down as CEO of the Company, with his resignation having no ties to any disputes over operations or policies. The Company is working on a separation agreement that includes certain benefits and restrictive covenants for Fleming. In his place, Ronald T. Nixon, the Executive Chairman with years of experience and multiple board roles, has been appointed as the new CEO. Nixon’s extensive background in strategic planning and investments positions him well to lead the Company moving forward.
See more insights into SMTI stock on TipRanks’ Stock Analysis page.
